13 patents currently held
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2038. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2038
Next term end
3
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2038 · High confidence
Also notable
Ends Sep 2040 · High confidence
Also notable
Ends Nov 2043 · High confidence
Collapsible Container for Blood Loss Assessment
US 11,493,502
Cited by 8 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2038.
Covering Assembly with Coagulant Compartment and Uses Thereof in a Blood Monitoring/Management System
US 11,559,466
Granted 2023. Computed term ends 2040.
Novel Minimal Surface Area Collection Device and Rapid Method for Estimating Low Blood Volume
US 12,736,549
Granted 2026. Too new for citation comparison; protection runs to 2043.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Mar 3 to 19, 2027 · next Mar 3
- 1 fee due Apr 10, 2027The maintenance fee for Container for Blood Volume Assessment (US 11,782,048) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for Blood Indicator Panel (US 11,860,155) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Method of Estimating Blood Volume | 11 in force | to May 2038 |
| Novel Minimal Surface Area Collection Device and Rapid Method for Estimating Low Blood Volume | 1 in force | to Nov 2043 |
| Covering Assembly with Coagulant Compartment and Uses Thereof in a Blood Monitoring/Management System | 1 in force | to Sep 2040 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,401,347 | Method of Estimating Blood Volume In force · High confidence | In force | High confidence | |
| US 11,293,913 | Container for Rapid Blood Detection and Blood Loss Assessment In force · High confidence | In force | High confidence | |
| US 11,493,501 | Blood Indicator Panel In force · High confidence | In force | High confidence | |
| US 11,493,502 | Collapsible Container for Blood Loss Assessment In force · High confidence | In force | High confidence | |
| US 11,761,950 | Container for Rapid Blood Detection and Blood Loss Assessment In force · High confidence | In force | High confidence | |
| US 11,782,048 | Container for Blood Volume Assessment In force · High confidence | In force | High confidence | |
| US 11,860,155 | Blood Indicator Panel In force · High confidence | In force | High confidence | |
| US 12,188,923 | Container for Blood Volume Assessment In force · High confidence | In force | High confidence | |
| US 12,631,618 | Collapsible Fluid Collection Container for Blood Detection and Measurement In force · High confidence | In force | High confidence | |
| US 12,133,716 | Method of Monitoring And/Or Measuring Blood Loss In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 13: 1 patent in force now held by others · 7 applications pending. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.